Birdwatch Note
2024-05-14 12:03:25 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
"Ozempic is not a weight loss drug" https://www.ozempic.com/ Ozempic is NOT licenced for weight loss. Ozempic is NOT licenced to treat heart attacks and/or strokes. Dr Amir Khan does not disclose payments from Novo Nordisk. https://search.disclosureuk.org.uk/ Celebrity endorsement of unlicensed/off label use of drugs. https://www.legislation.gov.uk/uksi/2012/1916/contents
Written by CAFC1BA2A775ACEC184ABEB9734CBAAD97973168E7F17B04E8D43E9E1B8AD74A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1790250512488509563
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1790352213639856352
- noteId - 1790352213639856352
- participantId -
- noteAuthorParticipantId - CAFC1BA2A775ACEC184ABEB9734CBAAD97973168E7F17B04E8D43E9E1B8AD74A Participant Details
- createdAtMillis - 1715688205524
- tweetId - 1790250512488509563
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- "Ozempic is not a weight loss drug" https://www.ozempic.com/ Ozempic is NOT licenced for weight loss. Ozempic is NOT licenced to treat heart attacks and/or strokes. Dr Amir Khan does not disclose payments from Novo Nordisk. https://search.disclosureuk.org.uk/ Celebrity endorsement of unlicensed/off label use of drugs. https://www.legislation.gov.uk/uksi/2012/1916/contents
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-05-14 12:03:25 UTC (1715688205524) |
2024-05-14 14:30:21 UTC (1715697021641) |
CURRENTLY_RATED_HELPFUL | 2024-05-16 01:24:29 UTC (1715822669564) |
CURRENTLY_RATED_HELPFUL | 2024-05-14 14:30:21 UTC (1715697021641) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-05-14 18:51:13 -0500 | Rating Details | |
| 2024-05-14 18:41:32 -0500 | Rating Details | |
| 2024-05-14 16:46:19 -0500 | Rating Details | |
| 2024-05-14 16:05:04 -0500 | Rating Details | |
| 2024-05-14 12:09:13 -0500 | Rating Details | |
| 2024-05-14 12:02:11 -0500 | Rating Details | |
| 2024-05-14 10:31:29 -0500 | Rating Details | |
| 2024-05-14 08:51:30 -0500 | Rating Details | |
| 2024-05-14 08:26:45 -0500 | Rating Details | |
| 2024-05-14 08:07:22 -0500 | Rating Details | |
| 2024-05-14 08:01:04 -0500 | Rating Details | |
| 2024-05-14 07:56:55 -0500 | Rating Details | |
| 2024-05-14 07:48:06 -0500 | Rating Details | |
| 2024-05-14 07:38:52 -0500 | Rating Details | |
| 2024-05-14 07:30:29 -0500 | Rating Details | |
| 2024-05-14 07:29:35 -0500 | Rating Details | |
| 2024-05-14 07:17:35 -0500 | Rating Details | |
| 2024-05-14 07:06:41 -0500 | Rating Details | |
| 2024-05-15 09:25:25 -0500 | Rating Details | |
| 2024-05-15 05:05:15 -0500 | Rating Details | |
| 2024-05-15 01:26:17 -0500 | Rating Details | |
| 2024-05-15 01:24:36 -0500 | Rating Details | |
| 2024-05-15 00:36:05 -0500 | Rating Details | |
| 2024-05-14 19:12:50 -0500 | Rating Details | |
| 2024-05-14 16:47:59 -0500 | Rating Details | |
| 2024-05-14 15:54:40 -0500 | Rating Details | |
| 2024-05-14 15:47:31 -0500 | Rating Details | |
| 2024-05-14 14:48:51 -0500 | Rating Details | |
| 2024-05-14 13:30:49 -0500 | Rating Details | |
| 2024-05-14 13:01:20 -0500 | Rating Details | |
| 2024-05-14 12:50:03 -0500 | Rating Details | |
| 2024-05-14 12:42:31 -0500 | Rating Details | |
| 2024-05-14 12:02:48 -0500 | Rating Details | |
| 2024-05-14 11:45:43 -0500 | Rating Details | |
| 2024-05-14 11:37:57 -0500 | Rating Details | |
| 2024-05-14 11:13:45 -0500 | Rating Details | |
| 2024-05-14 11:05:59 -0500 | Rating Details | |
| 2024-05-14 10:11:36 -0500 | Rating Details | |
| 2024-05-14 09:51:12 -0500 | Rating Details | |
| 2024-05-14 08:56:07 -0500 | Rating Details | |
| 2024-05-14 08:34:31 -0500 | Rating Details | |
| 2024-05-14 08:28:57 -0500 | Rating Details | |
| 2024-05-14 07:27:42 -0500 | Rating Details | |
| 2024-05-14 07:21:35 -0500 | Rating Details | |
| 2024-05-14 07:21:32 -0500 | Rating Details | |
| 2024-05-14 07:17:51 -0500 | Rating Details | |
| 2024-05-14 07:08:57 -0500 | Rating Details | |
| 2024-05-16 03:48:02 -0500 | Rating Details | |
| 2024-05-16 02:21:00 -0500 | Rating Details | |
| 2024-05-16 01:29:34 -0500 | Rating Details | |
| 2024-05-15 11:38:44 -0500 | Rating Details | |
| 2024-05-15 04:54:22 -0500 | Rating Details | |
| 2024-05-15 01:55:59 -0500 | Rating Details | |
| 2024-05-14 22:38:15 -0500 | Rating Details | |
| 2024-05-14 20:15:19 -0500 | Rating Details | |
| 2024-05-14 18:51:17 -0500 | Rating Details | |
| 2024-05-14 17:16:23 -0500 | Rating Details | |
| 2024-05-14 17:13:18 -0500 | Rating Details | |
| 2024-05-14 17:09:13 -0500 | Rating Details | |
| 2024-05-14 16:59:55 -0500 | Rating Details | |
| 2024-05-14 15:00:06 -0500 | Rating Details | |
| 2024-05-14 14:23:09 -0500 | Rating Details | |
| 2024-05-14 13:57:53 -0500 | Rating Details | |
| 2024-05-14 13:14:48 -0500 | Rating Details | |
| 2024-05-14 10:48:30 -0500 | Rating Details | |
| 2024-05-14 10:45:41 -0500 | Rating Details | |
| 2024-05-14 10:35:07 -0500 | Rating Details | |
| 2024-05-14 09:27:34 -0500 | Rating Details | |
| 2024-05-14 09:12:58 -0500 | Rating Details | |
| 2024-05-14 08:57:16 -0500 | Rating Details | |
| 2024-05-14 08:46:14 -0500 | Rating Details | |
| 2024-05-14 08:37:37 -0500 | Rating Details | |
| 2024-05-14 08:03:56 -0500 | Rating Details | |
| 2024-05-14 07:50:04 -0500 | Rating Details | |
| 2024-05-14 07:39:44 -0500 | Rating Details | |
| 2024-05-14 07:14:48 -0500 | Rating Details | |
| 2024-05-17 01:03:34 -0500 | Rating Details | |
| 2024-05-16 23:57:29 -0500 | Rating Details | |
| 2024-05-15 11:45:20 -0500 | Rating Details | |
| 2024-05-15 08:01:05 -0500 | Rating Details | |
| 2024-05-15 00:57:58 -0500 | Rating Details | |
| 2024-05-15 00:57:07 -0500 | Rating Details | |
| 2024-05-15 00:10:37 -0500 | Rating Details | |
| 2024-05-14 18:54:20 -0500 | Rating Details | |
| 2024-05-14 18:13:58 -0500 | Rating Details | |
| 2024-05-14 14:15:50 -0500 | Rating Details | |
| 2024-05-14 12:53:05 -0500 | Rating Details | |
| 2024-05-14 11:35:28 -0500 | Rating Details | |
| 2024-05-14 11:28:30 -0500 | Rating Details | |
| 2024-05-14 10:01:24 -0500 | Rating Details | |
| 2024-05-14 09:48:05 -0500 | Rating Details | |
| 2024-05-14 09:09:24 -0500 | Rating Details | |
| 2024-05-14 08:52:17 -0500 | Rating Details | |
| 2024-05-16 03:54:37 -0500 | Rating Details | |
| 2024-05-15 14:15:48 -0500 | Rating Details | |
| 2024-05-14 15:27:15 -0500 | Rating Details | |
| 2024-05-14 09:12:12 -0500 | Rating Details | |
| 2024-05-14 09:09:51 -0500 | Rating Details | |
| 2024-05-14 08:03:28 -0500 | Rating Details | |
| 2024-05-14 21:20:34 -0500 | Rating Details | |
| 2024-05-14 10:12:16 -0500 | Rating Details | |
| 2024-05-14 12:27:02 -0500 | Rating Details | |
| 2024-05-26 02:22:45 -0500 | Rating Details | |
| 2024-05-16 03:30:50 -0500 | Rating Details | |
| 2024-05-15 11:31:43 -0500 | Rating Details | |
| 2024-05-15 08:27:40 -0500 | Rating Details | |
| 2024-05-15 02:48:15 -0500 | Rating Details | |
| 2024-05-15 02:08:23 -0500 | Rating Details | |
| 2024-05-14 19:34:51 -0500 | Rating Details | |
| 2024-05-14 17:41:37 -0500 | Rating Details | |
| 2024-05-14 16:52:19 -0500 | Rating Details | |
| 2024-05-14 16:48:46 -0500 | Rating Details | |
| 2024-05-14 14:02:49 -0500 | Rating Details | |
| 2024-05-14 12:31:22 -0500 | Rating Details | |
| 2024-05-14 11:37:05 -0500 | Rating Details | |
| 2024-05-14 09:14:29 -0500 | Rating Details | |
| 2024-05-14 07:12:12 -0500 | Rating Details | |
| 2024-05-17 01:17:32 -0500 | Rating Details | |
| 2024-05-31 17:21:38 -0500 | Rating Details | |
| 2024-05-16 21:24:31 -0500 | Rating Details |